← All Signals

🏥 FDA: Annora Pharma Private Limited — Class III

healthcareneutralSource: FDA
75%Confidence
0Views
FDASource
2026-04-14Date

Summary

Annora Pharma's Class III recall for wrong tablets in Pitavastatin bottles shows packaging errors, posing a low health risk but highlighting quality control failures. This could strain relationships with Northstar Rx and prompt audits of other products from this manufacturer.

Actionable: Verify quality assurance protocols for other drugs manufactured by Annora Pharma.

AI Confidence: 75%

Data Points

firmAnnora Pharma Private Limited
classificationClass III
statusOngoing
distributionTN
productPitavastatin Tablets, 2 mg, packaged in 90-count bottles, Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Annora Phar

Get Signals Instantly

Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.

Subscribe Now